Axogen, Inc. (AXGN)
Axogen makes products for peripheral nerve repair, sold to surgeons and other healthcare providers. It last closed at $55.37 on Nov 17, down 0.02% on the day. The average 12-month price target from 8 analysts is $56.63 (+2.3% from the last close), with a high of $60.00 and a low of $52.00. Analyst consensus is Strong Buy, based on the latest ratings from 8 firms (8 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 4 whale options trades in AXGN, 75% of them bullish and 25% bearish.
Key Stats
Last 12 monthsNot reported for this period.
From AXGN's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 28). Last 12 months adds up the four latest quarters.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →Based on 8 analysts who set a price target on AXGN in the past 90 days. The average target is $56.63, with a high of $60.00 and a low of $52.00, compared with the last close of $55.37.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 29 | Canaccord Genuity | Target raised | Buy | $55 → $60 |
| Oct 29 | Leerink Partners | Maintained | Buy | $56 |
| Oct 29 | Barclays | Target raised | Buy | $50 → $60 |
| Oct 29 | Truist Securities | Target raised | Buy | $53 → $60 |
| Oct 29 | Wells Fargo | Maintained | Buy | $56 |
Technical Analysis
The stock is 13% above its 20 day and 21% above its 50 day average. It is 26% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 68), near overbought. The nearest support is the Pivot S1 at $54.45, and the nearest resistance the Pivot at $55.66.
| RSI (14) | 68.23 | Strong, overbought above 70 | Neutral |
| MACD | 4.02 | Above its signal line | Bullish |
| Stochastic | 73.6 | Middle of its range | Neutral |
| ADX (14) | 44.9 | Strong uptrend | |
| Williams %R | -35.8 | Oversold below −80, overbought above −20 | Neutral |
| CCI (20) | 91.5 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | +11.9% | Change over 10 sessions | Bullish |
| ATR (14) | $2.77 | Typical daily range, 5.0% of price |
| RSI (14) | 65.50 | Strong, overbought above 70 | Neutral |
| MACD | 2.99 | Above its signal line | Bullish |
| Stochastic | 84.3 | Near the top of its range | Overbought |
| ADX (14) | 29.2 | Trending up | |
| Williams %R | -17.0 | Oversold below −80, overbought above −20 | Overbought |
| CCI (20) | 156.5 | Oversold below −100, overbought above 100 | Overbought |
| Rate of change | +31.3% | Change over 10 sessions | Bullish |
| ATR (14) | $5.42 | Typical daily range, 9.8% of price |
What happened before
See how AXGN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How AXGN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
Whale Options Flow
90DNo whale options trades in AXGN in the last 90 days.
AXGN Institutional Ownership
Full report →- ●134 buying vs 123 selling
- ▲Held by funds +9.2 pts
- ●Funds holding -2
- ▲Superinvestors: 3 added, 1 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 253 | 255 | −0.8% |
| In funds' top 10 | 5 | 6 | −16.7% |
| Held by funds | 99.8% | 90.6% | +9.2 pts |
| New / increased | 36 / 98 | 50 / 111 | −16.8% |
| Reduced / sold out | 83 / 40 | 64 / 19 | +48.2% |
| Put/call ratio | 0.00 | – | – |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AXGN is in one of them and how their past AXGN trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered AXGN in an article yet. Here's the latest on the wider market.
AXGN Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Donna ShalalaD · FL | Sell | $1K – $15K | Jun 24, 2019 | Apr 27, 2020 | 308 d |
| Donna ShalalaD · FL | Buy | $1K – $15K | Apr 16, 2019 | Apr 27, 2020 | 377 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Axogen
Axogen is based in Alachua, Florida, and develops and sells products for repairing peripheral nerves, the pathways that carry movement and sensation signals throughout the body. Its main offerings include nerve grafts for bridging severed nerves, nerve connectors and protectors made from pig tissue, and a soft tissue matrix made from amniotic membrane. Surgeons and other healthcare providers use these products in surgeries to treat traumatic injuries, dental and orthopedic procedures, and breast reconstruction. Its products are sold mainly in the United States, with sales also in Canada, Germany, the United Kingdom, Spain and several other countries.
- Headquarters
- Alachua, FL




